First Time Loading...

Philogen SpA
MIL:PHIL

Watchlist Manager
Philogen SpA Logo
Philogen SpA
MIL:PHIL
Watchlist
Price: 17.9 EUR 0.28% Market Closed
Updated: May 10, 2024

Wall Street
Price Targets

PHIL Price Targets Summary
Philogen SpA

Wall Street analysts forecast PHIL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHIL is 23.97 EUR with a low forecast of 22.22 EUR and a high forecast of 26.25 EUR.

Lowest
Price Target
22.22 EUR
24% Upside
Average
Price Target
23.97 EUR
34% Upside
Highest
Price Target
26.25 EUR
47% Upside
Philogen SpA Competitors:
Price Targets
DTIL
Precision BioSciences Inc
217% Upside
ASND
Ascendis Pharma A/S
38% Upside
ARQT
Arcutis Biotherapeutics Inc
129% Upside
SRZN
Surrozen Inc
229% Upside
SPRY
ARS Pharmaceuticals Inc
122% Upside
APGE
Apogee Therapeutics Inc
65% Upside
300439
MedicalSystem Biotechnology Co Ltd
124% Upside
ZEAL
Zealand Pharma A/S
22% Upside

Revenue
Forecast

Revenue Estimate
Philogen SpA

For the last 5 years the compound annual growth rate for Philogen SpA's revenue is 11%. The projected CAGR for the next 3 years is 40%.

11%
Past Growth
40%
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Philogen SpA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Net Income
Forecast

Net Income Estimate
Philogen SpA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHIL's stock price target?
Price Target
23.97 EUR

According to Wall Street analysts, the average 1-year price target for PHIL is 23.97 EUR with a low forecast of 22.22 EUR and a high forecast of 26.25 EUR.

What is Philogen SpA's Revenue forecast?
Projected CAGR
40%

For the last 5 years the compound annual growth rate for Philogen SpA's revenue is 11%. The projected CAGR for the next 3 years is 40%.